Perrigo Co PLC (NYSE:PRGO)
$ 30.71 -0.31 (-1%) Market Cap: 4.19 Bil Enterprise Value: 7.60 Bil PE Ratio: 0 PB Ratio: 0.89 GF Score: 70/100

Perrigo Company PLC at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 01:10PM GMT
Release Date Price: $52.77 (+3.69%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

All right. I think we can get started here. So thank you so much, everyone, for joining the Perrigo session. I just need to refer you to disclaimers at www.morganstanley.com/researchdisclosures.

It's very much my pleasure to welcome Murray Kessler, President and CEO; and Ray Silcock, who is CFO of the company. They both have extensive track records and backgrounds in building companies and creating shareholder value in the consumer products area. And so we appreciate you being with us here today.

Murray, I thought it would be great to have you kick it off with some opening remarks.

Murray S. Kessler
Perrigo Company plc - CEO, President & Director

I appreciate that, and thanks for having us here, David. We are, as a company, going through a major transformation. If you follow the history of Perrigo over the last 15 years, it's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot